| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |